PRESS RELEASES

Dec 19, 2017
Clinical Genomics Pathology Inc. Receives Accreditation from College of American Pathologists (CAP) for Liquid Biopsy Lab

Dec 12, 2017
Roy Davis joins liquid biopsy company Clinical Genomics board of directors

Nov 30, 2017
Clinical Genomics receives CSIRO award for Entrepreneurship in Science

Nov 28, 2017
Clinical Genomics appoints Roger Moody as Chief Financial Officer

Nov 13, 2017
Clinical Genomics and Quest Diagnostics announce FDA 510(K) clearance of InSure® ONE™

Oct 19, 2017
Clinical Genomics Working with Leading Cancer Center to Evaluate Colvera™ in Patients with Colorectal Cancer

Aug 31, 2017
“Liquid biopsy” colorectal cancer blood test celebrates Eureka moment

Aug 24, 2017
Clinical Genomics hits a milestone in colon cancer prevention

Aug 21, 2017
QIAGEN and Clinical Genomics partner on liquid biopsies to monitor patients for recurrence of colorectal cancer

Aug 03, 2017
New “liquid biopsy” blood test for colorectal cancer set for Eureka moment

Jun 09, 2017
Data Presented at ASCO Annual 2017 Shows Clinical Utility of Colvera™ in Assessing and Monitoring Patients Following Surgical Resection of Colorectal Cancer

May 31, 2017
Clinical Genomics to Present Data at ASCO Supporting Clinical Utility of Colvera™ in Assessing and Monitoring Patients Following Surgical Resection of Colorectal Cancer

Mar 08, 2017
Clinical Genomics Announces Participation in Fortified Provider Network and MultiPlan

Jan 18, 2017
Clinical Genomics to Present Data at ASCO GI Supporting Clinical Utility of Colvera™ in Assessing and Monitoring Patients Following Surgical Resection of Colorectal Cancer

Dec 21, 2016
Clinical Genomics Appoints Mark Boyle President, In Vitro Diagnostics

Dec 20, 2016
Clinical Genomics Announces the Launch of Colvera™ for Colorectal Cancer Recurrence Monitoring

Nov 14, 2016
Clinical Genomics Announces Appointment of Michael Dugan, M.D. as Chief Medical Officer

Oct 13, 2016
Clinical Genomics Strengthens its Leadership Team with Multiple Key Appointments

Oct 12, 2016
Data Published in Cancer Medicine Demonstrate Clinical Genomics’ Blood Test for Colorectal Cancer Recurrence is Two-Fold More Sensitive than CEA Test

Sep 29, 2016
Clinical Genomics Celebrates Ten Years of Innovation

Jun 02, 2016
Clinical Genomics Announces Implementation of UNIConnect® Precision Molecular Diagnostics Laboratory Information Management System

Mar 23, 2016
Clinical Genomics Announces Closing of $15 Million Series A Financing Round

Mar 02, 2016
Clinical Genomics and its exclusive China partner BioChain Group receive CFDA approval for InSure® FIT™ in China

Jan 25, 2016
Clinical Genomics Presents Data Supporting Novel 2-Gene Blood Test for Earlier Detection of Colorectal Cancer Recurrence at ASCO GI

Jan 21, 2016
Clinical Genomics to Present Data Supporting Utility of 2-Gene Blood Test for Colorectal Cancer Recurrence at ASCO GI

Aug 10, 2015
Cancer screening pioneer appointed first ‘Emeritus Scientist’ by Clinical Genomics